United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - american ginseng (unii: 8w75vcv53q) (american ginseng - unii:8w75vcv53q), chaste tree (unii: 433osf3u8a) (chaste tree - unii:433osf3u8a), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), dieffenbachia seguine (unii: 01800c6e6b) (dieffenbachia seguine - unii:01800c6e6b), potassium bromide (unii: osd78555zm) (bromide ion - unii:952902ix06), strychnine phosphate dihydrate (unii: td67syy51d) (strychnine - unii:h9y79vd43j), lytta vesicatoria (unii: 3q034ro3bt) (lytta vesicatoria - unii:3q034ro - american ginseng 4 [hp_x] in 1 ml - temporary relief of symptoms related to male hormonal problems such as libido difficulties, fatigue, urinary problems related to bladder, prostate and depression.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. temporary relief of symptoms related to male hormonal problems such as libido difficulties, fatigue, urinary problems related to bladder, prostate and depression.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

feelgood health - saw palmetto (unii: j7wwh9m8qs) (saw palmetto - unii:j7wwh9m8qs) - saw palmetto 6 [hp_c]

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

reckitt benckiser healthcare (uk) ltd - sodium alginate; potassium bicarbonate - oral suspension - 100mg/1ml ; 20mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

forum health products ltd - sodium alginate; potassium bicarbonate - oral suspension - 100mg/1ml ; 20mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

forum health products ltd - sodium alginate; potassium bicarbonate - oral suspension - 100mg/1ml ; 20mg/1ml

European Union - English - EMA (European Medicines Agency)

steba biotech s.a - padeliporfin di-potassium - prostatic neoplasms - antineoplastic agents - tookad is indicated as monotherapy for adult patients with previously untreated, unilateral, low risk, adenocarcinoma of the prostate with a life expectancy ≥ 10 years and:clinical stage t1c or t2a;gleason score ≤ 6, based on high-resolution biopsy strategies;psa ≤ 10 ng/ml;3 positive cancer cores with a maximum cancer core length of 5 mm in any one core or 1-2 positive cancer cores with ≥ 50 % cancer involvement in any one core or a psa density ≥ 0.15 ng/ml/cm³.

United States - English - NLM (National Library of Medicine)

dna labs, inc. - serenoa repens whole (unii: 487dxm62f2) (serenoa repens whole - unii:487dxm62f2), agathosma crenulata whole (unii: b6642j883v) (agathosma crenulata whole - unii:b6642j883v), chimaphila umbellata (unii: wck21a9w9j) (chimaphila umbellata - unii:wck21a9w9j), elymus repens whole (unii: be5076899x) (elymus repens whole - unii:be5076899x), selenium (unii: h6241uj22b) (selenium - unii:h6241uj22b), bos taurus prostate gland (unii: 1p66fxu2mw) (bos taurus prostate gland - unii:1p66fxu2mw) - serenoa repens whole 2 [hp_x] in 1 ml - support for the prostate frequent and scanty urination in men.

United States - English - NLM (National Library of Medicine)

sunshine lake pharma co., ltd. - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - oral olanzapine is indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13-17), efficacy was established in one 6-week trial [see clinical studies ( 14.1)] . when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see warnings and precautions ( 5.5] . monotherapy — oral olanzapine is indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i disord

Australia - English - Department of Health (Therapeutic Goods Administration)

ultramed - 38426 - brachytherapy applicator, manual, prostate - the single use template assists in the manual positioning of needles and applicators in cryo- / (ldr- / hdr) brachytherapy treatment and biopsies of the prostate.

Australia - English - Department of Health (Therapeutic Goods Administration)

ultramed - 38426 - brachytherapy applicator, manual, prostate - the brachytherapy equipment assists in the manual positioning of needles in the interstitial brachytherapy treatment of the prostate.